| Drug Type Small molecule drug | 
| Synonyms Compound 10(Université Côte d'Azur/Roca) | 
| Target | 
| Action antagonists | 
| Mechanism CXCR1 antagonists(C-X-C motif chemokine receptor 1 antagonists), CXCR2 antagonists(C-X-C motif chemokine receptor 2 antagonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC14H8Cl2N4O3S | 
| InChIKeyFCQTYYYNDNQUIQ-UHFFFAOYSA-N | 
| CAS Registry2415653-55-1 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Preclinical | France  | 03 Apr 2024 | |
| Neoplasms | Preclinical | France  | 03 Apr 2024 | 





